[HTML][HTML] Understanding bacterial biofilms: From definition to treatment strategies
A Zhao, J Sun, Y Liu - Frontiers in Cellular and Infection Microbiology, 2023 - frontiersin.org
Bacterial biofilms are complex microbial communities encased in extracellular polymers.
Their formation is a multi-step process. Biofilms are a significant problem in treating bacterial …
Their formation is a multi-step process. Biofilms are a significant problem in treating bacterial …
Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern
L Boyanova, P Hadzhiyski, R Gergova, R Markovska - Antibiotics, 2023 - mdpi.com
Antibiotic resistance among Helicobacter pylori strains is the major cause of eradication
failure. Resistance prevalence is dynamic and can greatly vary among countries over the …
failure. Resistance prevalence is dynamic and can greatly vary among countries over the …
Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review
M Liu, H Gao, J Miao, Z Zhang, L Zheng, F Li… - Frontiers in …, 2024 - frontiersin.org
The global prevalence of Helicobacter pylori (H. pylori) infection remains high, indicating a
persistent presence of this pathogenic bacterium capable of infecting humans. This review …
persistent presence of this pathogenic bacterium capable of infecting humans. This review …
Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents
OM Al-Fakhrany, E Elekhnawy - Archives of Microbiology, 2023 - Springer
Helicobacter pylori is considered one of the most prevalent human pathogenic microbes
globally. It is the main cause of a number of gastrointestinal ailments, including peptic and …
globally. It is the main cause of a number of gastrointestinal ailments, including peptic and …
Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria
Y Zou, X Chen, Y Sun, P Li, M Xu, P Fang… - Journal of Controlled …, 2022 - Elsevier
Biofilms and intracellular survival tremendously help Helicobacter pylori (H. pylori) escape
from antibacterial agents attacking, therefore issuing extreme challenges to clinical …
from antibacterial agents attacking, therefore issuing extreme challenges to clinical …
Therapeutic effect of demethylated hydroxylated phillygenin derivative on Helicobacter pylori infection
RJ Li, J Xu, X Wang, L Liao, X Wei, P Xie… - Frontiers in …, 2023 - frontiersin.org
Modifying and transforming natural antibacterial products is a novel idea for developing new
efficacious compounds. Phillygenin has an inhibitory effect on H. pylori. The aim of the …
efficacious compounds. Phillygenin has an inhibitory effect on H. pylori. The aim of the …
Phototherapy and Mechanism Exploration of Biofilm and Multidrug‐Resistant Helicobacter pylori by Bacteria‐Targeted NIR Photosensitizer
Y Qiao, Y Ma, Y Tong, W Liu, S Wang, Y Zheng, C Men… - Small, 2023 - Wiley Online Library
Helicobacter pylori (H. pylori) infection has been the leading cause of gastric cancer
development. In recent years, the resistance of H. pylori against antibiotic treatment has …
development. In recent years, the resistance of H. pylori against antibiotic treatment has …
[PDF][PDF] Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation
Peptic ulcer disease (PUD) is one of the most prevalent gastro intestinal disorder which
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …
High-throughput screening and molecular dynamics simulations of natural products targeting LuxS/AI-2 system as a novel antibacterial strategy for antibiotic …
AK Ashok, TS Gnanasekaran… - Journal of …, 2024 - Taylor & Francis
The main goal of treating any Helicobacter pylori (H. pylori)-related gastrointestinal disease
is completely eradicating infection. Falling eradication efficiency, off-target effects, and …
is completely eradicating infection. Falling eradication efficiency, off-target effects, and …
Curcumin clarithromycin nano-form a promising agent to fight Helicobacterpylori infections
FM Mosallam, MM Bendary, R Elshimy… - World Journal of …, 2023 - Springer
Helicobacter pylori (H. pylori) is the main cause of gastric diseases. However, the traditional
antibiotic treatment of H. pylori is limited due to increased antibiotic resistance, low efficacy …
antibiotic treatment of H. pylori is limited due to increased antibiotic resistance, low efficacy …